NCT01606111 - The CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

Traumatic Brain Injury

Interventions

DRUG

Cerebrolysin

IV infusion, 50 ml/day, 10 days (treatment cycle will be repeated one and two months later if patient has a score of less than 7 in the extended Glasgow Outcome Scale on Day 30)

DRUG

0.9% NaCl, saline

IV infusion, 50 ml/day, 10 days (treatment cycle will be repeated one and two months later if patient has a score of less than 7 in the extended Glasgow Outcome Scale on Day 30)

Trial Locations (1)

Unknown

Prince of Wales Hospital, Hong Kong